Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung Cancer
PHASE3
This is a randomized, controlled, multicenter clinical study that enrolled ...
Status
Not Yet Recruiting
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy
PHASE2
This study aims to evaluate the efficacy and safety of adebrelimab consolid...
A Phase II Clinical Study of Induction Adebrelimab Combined With Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC)
PHASE2
This study aims to evaluate the efficacy and safety of induction Adebrelima...
Neoadjuvant Radiotherapy Combined With NALIRIFOX and Adebrelimab in pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Randomized, Phase II Clinical Trial
PHASE2
To explore the efficacy and safety of radiotherapy combined with Adebrelima...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou 510060, P. R. China
Long-Course Concurrent Chemoradiotherapy With Adebrelimab and Apatinib as Neoadjuvant Therapy for Locally Advanced/Low-Lying Rectal Cancer Requiring Sphincter Preservation
PHASE2
To observe and evaluate the efficacy and safety of neoadjuvant long-course ...
Status
Active Not Recruiting
Location
No. 150, Haping Road, Nangang District, Harbin, Heilongjiang Province, China